StockData
Globus Medical Inc logo

Globus Medical Inc (GMED) stock

GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3044% below fair value
$69.99−0.51 (-0.72%)

Close on Nov 17, 2026Market cap $9.40BP/E 17.9Yield –

Globus Medical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Globus Medical's ebitda for the twelve months ending Jun 30, 2026 was $919.44M, up 66.5% year over year. For fiscal 2025 it was $756.66M, up 80.4% from the year before. Over ten years it grew 14.4% a year on average. The highest annual figure on record is $756.66M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$756.66M+80.4%
FY2024Dec 31, 2024$419.38M+50.5%
FY2023Dec 31, 2023$278.67M-5.9%
FY2022Dec 31, 2022$296.20M+22.5%
FY2021Dec 31, 2021$241.82M+38.7%
FY2020Dec 31, 2020$174.31M-22.4%
FY2019Dec 31, 2019$224.72M+6.5%
FY2018Dec 31, 2018$210.96M+3.5%
FY2017Dec 31, 2017$203.91M+5.7%
FY2016Dec 31, 2016$192.91M-1.7%
FY2015Dec 31, 2015$196.31M+22.6%
FY2014Dec 31, 2014$160.12M+32.3%
FY2013Dec 31, 2013$121.07M-8.9%
FY2012Dec 31, 2012$132.90M+16.3%
FY2011Dec 31, 2011$114.31M+11.1%
FY2010Dec 31, 2010$102.88M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$251.93M+71.7%
Q1 FY2026Mar 31, 2026$220.24M+35.4%
Q4 FY2025Dec 31, 2025$238.35M+86.4%
Q3 FY2025Sep 30, 2025$208.91M+81.6%
Q2 FY2025Jun 30, 2025$146.74M+29.6%
Q1 FY2025Mar 31, 2025$162.66M+157.1%
Q4 FY2024Dec 31, 2024$127.87M+55.8%
Q3 FY2024Sep 30, 2024$115.05M+204.4%
Q2 FY2024Jun 30, 2024$113.21M+34.3%
Q1 FY2024Mar 31, 2024$63.26M-15.1%
Q4 FY2023Dec 31, 2023$82.08M+15.7%
Q3 FY2023Sep 30, 2023$37.79M-51.1%
Q2 FY2023Jun 30, 2023$84.29M-0.5%
Q1 FY2023Mar 31, 2023$74.51M+17.7%
Q4 FY2022Dec 31, 2022$70.94M+102.5%
Q3 FY2022Sep 30, 2022$77.28M+10.3%
Q2 FY2022Jun 30, 2022$84.70M+30.3%
Q1 FY2022Mar 31, 2022$63.28M-11.7%
Q4 FY2021Dec 31, 2021$35.03M-53.6%
Q3 FY2021Sep 30, 2021$70.08M+5.7%
Q2 FY2021Jun 30, 2021$65.01M–
Q1 FY2021Mar 31, 2021$71.71M+66.7%
Q4 FY2020Dec 31, 2020$75.44M+17.8%
Q3 FY2020Sep 30, 2020$66.31M+19.2%
Q2 FY2020Jun 30, 2020-$10.46M-118.8%
Q1 FY2020Mar 31, 2020$43.02M-12.8%
Q4 FY2019Dec 31, 2019$64.03M–
Q3 FY2019Sep 30, 2019$55.64M-8.3%
Q2 FY2019Jun 30, 2019$55.73M+7.4%
Q1 FY2019Mar 31, 2019$49.33M-10.5%
Q4 FY2018Dec 31, 2018$0-100.0%
Q3 FY2018Sep 30, 2018$60.70M+30.2%
Q2 FY2018Jun 30, 2018$51.90M+8.0%
Q1 FY2018Mar 31, 2018$55.11M+4.9%
Q4 FY2017Dec 31, 2017$56.65M+7.0%
Q3 FY2017Sep 30, 2017$46.63M+2.5%
Q2 FY2017Jun 30, 2017$48.07M–
Q1 FY2017Mar 31, 2017$52.55M–
Q4 FY2016Dec 31, 2016$52.96M–
Q3 FY2016Sep 30, 2016$45.49M–

More Globus Medical figures

See a number that looks wrong?